Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps

Clicks: 358
ID: 112861
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #84 of 183 articles by views in The New England journal of medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Caps for spending on specialty drugs were associated with substantial reductions in spending on specialty drugs among patients with the highest out-of-pocket costs, without detectable increases in health-plan spending, a proxy for future insurance premiums. (Funded by the Robert Wood Johnson Foundat …
Reference Key
k2020thepatient Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yeung K;Barthold D;Dusetzina SB;Basu A;;
Journal The New England journal of medicine
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32757524
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Insurance humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult middle aged Comparative Study United States pmid:32757524 doi:10.1056/nejmsa1910366 kai yeung douglas barthold anirban basu chronic disease / drug therapy* chronic disease / economics cost sharing / economics cost sharing / legislation & jurisprudence* delaware drug costs / legislation & jurisprudence* health expenditures / statistics & numerical data* pharmaceutical services / economics* pharmaceutical services / legislation & jurisprudence louisiana maryland prescription fees / legislation & jurisprudence state government*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.